Clinical trial
Phase 1 Trial of Idebenone to Treat Patients With Friedreich's Ataxia
NCT00078481 · National Institute of Neurological Disorders and Stroke (NINDS), NIH · Completed
Key facts
| NCT number | NCT00078481 |
|---|---|
| Title | Phase 1 Trial of Idebenone to Treat Patients With Friedreich's Ataxia |
| Official title | Phase 1B Clinical Trial to Establish the Safety and Tolerability of a Multiple-Dose Regimen of Idebenone Administered to Patients With Friedreich's Ataxia |
| Lead sponsor | National Institute of Neurological Disorders and Stroke (NINDS), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Friedreich Ataxia |
| Intervention type | Drug |
| Interventions | Idebenone |
| Enrollment | 16 |
| Start date | Feb 1, 2004 |
| Completion | Apr 1, 2006 |
| First posted | Mar 1, 2004 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: